Clinical Indication

Neuroendocrine tumours

Local guidance

Reclassified from simple amber to red November 2016

Date of classification

May 2015


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.